Effect of Selenium on improvement of clinical manifestations and reducing hospitalization in patients with COVID 19

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201028049175N9

Enrollment

160

Registered

2021-09-06

Start date

2021-09-22

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Coronavirus disease 2019 (COVID 19). Condition 2: Selenium. COVID-19, virus identified Dietary selenium deficiency

Interventions

Intervention 1: Intervention group: 1 mg of selenium intravenously will be injected for 14 days added to routine treatment protocol. Intervention 2: Control group: Distilled water that is similar to S

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with moderate COVID 19 infection Patients with severe COVID 19 infection Patients who have informed consent

Exclusion criteria

Exclusion criteria: Renal failure (Glomerular filtration rate 70 or under)

Design outcomes

Primary

Measure	Time frame
Length of hospitalization. Timepoint: After discharge. Method of measurement: Days.;Length of ICU stay. Timepoint: After discharge. Method of measurement: Days.;Duration of using mechanical ventilation. Timepoint: After discharge. Method of measurement: Days.;Duration of fever. Timepoint: After discharge. Method of measurement: Days.;Level of atrial oxygen saturation (SpO2). Timepoint: Daily from first day to 14th day. Method of measurement: pulse oximetry.	—

Measure

Time frame

Length of hospitalization. Timepoint: After discharge. Method of measurement: Days.;Length of ICU stay. Timepoint: After discharge. Method of measurement: Days.;Duration of using mechanical ventilation. Timepoint: After discharge. Method of measurement: Days.;Duration of fever. Timepoint: After discharge. Method of measurement: Days.;Level of atrial oxygen saturation (SpO2). Timepoint: Daily from first day to 14th day. Method of measurement: pulse oximetry.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Sarmadian

Arak University of Medical Sciences

hosseinsarmadian2015@yahoo.com+98 86 3313 4715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026